Disc Medicine, Inc.
IRONNasdaqCIK 1816736HealthcareFiscal year ends Dec 31
Reports and events: 157 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2617:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-432228 |
| 2026-10-2217:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429105 |
| 2026-10-1907:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-424649 |
| 2026-09-1008:48 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387351 |
| 2026-07-3008:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-325034 |
| 2026-07-3008:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-325031 |
| 2026-06-3016:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-290542 |
| 2026-06-2416:22 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-281096 |
| 2026-05-0508:33 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-205192 |
| 2026-05-0508:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205187 |
| 2026-04-2817:02 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001193125-26-187646 |
| 2026-02-2716:31 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-26-082855 |
| 2026-02-2608:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073602 |
| 2026-02-2608:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073594 |
| 2026-02-1707:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-053066 |
| 2026-02-1316:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-051504 |
| 2026-01-1208:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009871 |
| 2025-12-1720:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001628098-25-000010 |
| 2025-12-0808:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310664 |
| 2025-11-0608:34 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268200 |
| 2025-11-0608:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268196 |
| 2025-10-2221:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-247406 |
| 2025-10-2209:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-245871 |
| 2025-10-2006:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242959 |
| 2025-10-1708:43 ET | 8-K | 8.01 Other events | 0001193125-25-242026 |
| 2025-10-0616:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-231911 |
| 2025-08-1519:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-022121 |
| 2025-08-0708:40 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001816736-25-000007 |
| 2025-08-0708:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816736-25-000006 |
| 2025-07-1408:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-095466 |
| 2025-06-1317:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-086352 |
| 2025-05-0708:37 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065069 |
| 2025-05-0708:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065031 |
| 2025-04-2416:44 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0000950170-25-058142 |
| 2025-03-1219:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000305 |
| 2025-03-0316:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-030811 |
| 2025-02-2708:17 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-028390 |
| 2025-02-2708:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-037650 |
| 2025-01-2416:09 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-012211 |
| 2025-01-2107:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-009095 |
| 2025-01-1009:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-003859 |
| 2024-12-0908:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134349 |
| 2024-11-1516:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-259855 |
| 2024-11-1208:26 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124650 |
| 2024-11-1208:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255200 |
| 2024-11-0808:49 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123718 |
| 2024-11-0407:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-120292 |
| 2024-10-2513:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-117318 |
| 2024-08-0808:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093357 |
| 2024-08-0808:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196507 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:53 ET. Listed shows no prices and gives no investment advice.